Evidence map›Paper›PMID 39810645›Full record

ReviewAnnals of medicine2025

Gut microbiota and endometrial cancer: research progress on the pathogenesis and application.

Weiqin Zheng, Xiaowen Lin, Huixin Chen, Ziling Yang, Han Zhao, Shibo Li, Tao Song, Yuhui Sun

Abstract readReview
In one paragraph

Review in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Research Progress of RAD51AP1 in Malignant Tumors of the Female Reproductive System.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weiqin ZhengDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID 0000-0001-9177-6362
Xiaowen LinDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Huixin ChenDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ziling YangDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Han ZhaoDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Shibo LiDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Tao SongDepartment of Cardiology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yuhui SunDepartment of Gynecology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the three major malignant tumors in women, the morbidity of endometrial cancer is second only to that of cervical cancer and is increasing yearly. Its etiological mechanism is not clear, and the risk factors are numerous and common and are closely related to obesity, hypertension, diabetes, etc. The gut microbiota has many strains, which play a considerable part in normal digestion and absorption in the human body and the regulation of the immune response. In the last few years, research on the gut microbiota has been unprecedentedly popular, and it has been confirmed that the gut microbiota closely correlates with the occurrence and development of all kinds of benign and malignant diseases. In this article, the effects of the gut microbiota and its metabolites on the occurrence and development of endometrial cancer is reviewed, and its application in the prevention, diagnosis and treatment of endometrial cancer is explored.

Indexed as

Endometrial NeoplasmsGastrointestinal MicrobiomeFemaleHumansRisk Factorsbiomarkerendometrial cancerestrogenGut microbiotahypertensioninsulin resistance

Identifiers

PMID39810645
PMCPMC11737052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.